Multi-parameter lead optimization to give an oral CHK1 inhibitor clinical candidate: (R)-5-((4-((morpholin-2-ylmethyl)amino)-5-(trifluoromethyl)pyridin-2-yl)amino)pyrazine-2-carbonitrile (CCT245737)

PDB Details

PDB ID
5F4N
Status
CURRENT
Deposition Date
2015-12-03
Modification Date
2016-06-22
Pubmed ID
27167172
Method
X-RAY DIFFRACTION
Resolution (Å)
1.91
UniProt Accessions
O14757

Mapping Results

Chain Terminus Site Consensus Site Rank Consensus Site Population
A C EDI 0 19
A C CMP 7 6
A N ATP 0 32
A N MPP 2 17
A N MT3 3 7
A N MPP 4 5

Mapping Results Viewer

Use your mouse to drag, rotate, and zoom. Select structure to view on the right using dropdown.
Powered by NGL

Legend

Color Name Hit Count